LEE Soo Chin
Professor and Senior Principal Investigator, Cancer Science Institute of Singapore, NUS
Head and Senior Consultant, Department of Hematology/Oncology, NUHS
Professor Lee Soo Chin’s laboratory focuses on novel therapeutics and predictive biomarkers in breast cancer. She has studied different novel treatment strategies, including using low-dose anti-angiogenic agent to improve chemotherapy delivery. Her team has identified a biomarker detectable in blood that predicts breast cancer recurrence, and that can be used to select patients for a novel targeted therapy. Her team has found a genetic variant common in Asians but rare in Caucasians to influence metabolism of a commonly used breast cancer drug, highlighting that inter-ethnic differences in genetic make-up could account for geographic differences in outcomes to anti-cancer treatment.